RT Journal Article
T1 Transcatheter Mitral Repair for Functional Mitral Regurgitation According to Left Ventricular Function: A Real-Life Propensity-Score Matched Study.
A1 Pascual, Isaac
A1 Carrasco-Chinchilla, Fernando
A1 Benito-Gonzalez, Tomas
A1 Li, Chi Hion
A1 Avanzas, Pablo
A1 Nombela-Franco, Luis
A1 Pan, Manuel
A1 Serrador Frutos, Ana
A1 Freixa, Xavier
A1 Trillo-Nouche, Ramiro
A1 Hernández-Antolín, Rosa A
A1 Andraka Ikazuriaga, Leire
A1 Cruz-Gonzalez, Ignacio
A1 López-Mínguez, Jose R
A1 Diez, Jose L
A1 Berenguer-Jofresa, Alberto
A1 Sanchis, Juan
A1 Ruiz-Quevedo, Valeriano
A1 Urbano-Carrillo, Cristobal
A1 Dominguez, Juan F Oteo
A1 Ortas-Nadal, Maria R
A1 Molina Navarro, Eduardo
A1 Carrillo, Xavier
A1 Alonso-Briales, Juan H
A1 Fernández-Vázquez, Felipe
A1 Asmarats Serra, Luis
A1 Hernandez-Vaquero, Daniel
A1 Jimenez-Quevedo, Pilar
A1 Mesa, Dolores
A1 Rodríguez-Gabella, Tania
A1 Regueiro, Ander
A1 Martinez Monzonís, Amparo
A1 Salido Tahoces, Luisa
A1 Ruiz Gomez, Lara
A1 Trejo-Velasco, Blanca
A1 Becerra-Muñoz, Victor M
A1 Garrote-Coloma, Carmen
A1 Fernández Peregrina, Estafanía
A1 Lorca, Rebeca
A1 Agustín, Jose A De
A1 Romero, Miguel
A1 Amat-Santos, Ignacio J
A1 Sabaté, Manel
A1 Alvarez, Ana B Cid
A1 Hernandez-Garcia, Jose M
A1 Gualis, Javier
A1 Arzamendi, Dabit
A1 Moris, Cesar
A1 Tirado-Conte, Gabriela
A1 Sánchez-Recalde, Angel
A1 Estevez-Loureiro, Rodrigo
K1 Mitraclip
K1 functional mitral regurgitation
K1 left ventricular ejection Fraction
K1 transcatheter
AB Transcatheter mitral valve repair (TMVR) could improve survival in functional mitral regurgitation (FMR), but it is necessary to consider the influence of left ventricular ejection fraction (LVEF). Therefore, we compare the outcomes after TMVR with Mitraclip® between two groups according to LVEF. In an observational registry study, we compared the outcomes in patients with FMR who underwent TMVR with and without LVEF  Among 535 FMR eligible patients, 144 patients with LVEF 30% (group 2) had similar propensity scores and were included in the analyses. The primary study endpoint was significantlly higher in group 1 (33.3% vs. 9.4%, p = 0.002). There was a maintained improvement in secondary endpoints without significant differences among groups. FMR patients with LVEF
SN 2077-0383
YR 2020
FD 2020-06-09
LK https://hdl.handle.net/10668/25845
UL https://hdl.handle.net/10668/25845
LA en
DS RISalud
RD Apr 17, 2025